As a selective monoamine oxidase B (MAO-B) inhibitor, XADAGO offers a unique mechanism of action that complements traditional therapies, pote ...

Holden and Ellsworth Police were at Titan Athletics Tuesday. They joined in on the Rock Steady Boxing group which aims to ...

The HealthWell Foundation®, an independent non-profit charitable organization that provides financial assistance for ...

About one-third of individuals with Parkinson’s disease experienced anxiety, and many of them reported that it disrupted ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

Parkinson’s Disease is a neurodegenerative disorder that affected predominately the Dopamine-producing neurons in a specific ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Ask the Expert, Dr. Juan Torres Reveron shares on Deep Brain Stimulation treatment for some individuals with Parkinson's disease.

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

Single and multi-dose studies of the small molecule TREM2 agonist VG-3927 clear early safety hurdle. Meanwhile, new findings ...

The video shows an incident in which a man was arrested. Decatur PD released it in response to a video circulating on social media.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...